Diagnosis, Vaccination, and Field Control of IBD: Bridging Gaps Between Theory and Practice

Despite widespread vaccination, Infectious Bursal Disease continues to cause outbreaks globally. The challenge lies not just in controlling the virus, but in adapting strategies to its evolving nature and field realities. 

Diagnostic Approaches: Choosing the Right Tool¹ 

Diagnosis of IBD depends on combining clinical suspicion with laboratory confirmation. During the acute phase, the virus is most reliably detected in the bursa within the first 3 days post-infection. 

Traditional methods like agar gel immunodiffusion (AGID) are simple but lack sensitivity. ELISA-based assays offer improved detection, especially when based on recombinant VP2 or VP3 proteins. 

Molecular diagnostics have become the gold standard. RT-PCR targeting the hypervariable VP2 region allows precise strain identification and phylogenetic analysis. Real-time RT-PCR further enhances sensitivity and throughput, making it suitable for large-scale surveillance. 

For field-level detection, LAMP assays and rapid strip tests provide quick and reliable results without sophisticated infrastructure. 

Vaccination Challenges in the Field 

Vaccination remains the cornerstone of IBD control, but its success is often compromised by several factors: 

• Interference from maternally derived antibodies (MDA)  

• Antigenic mismatch with circulating strains  

• Improper timing of vaccination  

Live attenuated vaccines, though widely used, carry risks of reversion to virulence and may fail against vvIBDV strains¹. Inactivated vaccines are primarily used in breeder flocks to confer maternal immunity, but they do not provide immediate protection to chicks. 

Optimizing Vaccination Strategies 

Timing is critical. Vaccinating too early leads to neutralization by MDA, while delayed vaccination leaves birds unprotected¹. Serological monitoring of antibody levels is therefore essential for determining the optimal vaccination window. 

Mass vaccination through drinking water or spray is practical, but uniformity of dose remains a challenge in field conditions. 

New-Generation Vaccines: Are They the Solution? 

Advances in vaccine technology are addressing many limitations of conventional vaccines. Subunit vaccines targeting VP2 offer safer alternatives with DIVA capability, though they require boosters². 

Virus-like particle (VLP) vaccines mimic the native virus structure without containing genetic material, offering strong immunogenicity and safety. DNA vaccines and immune complex vaccines provide additional strategies, particularly in overcoming MDA interference¹. 

Vector-based vaccines, such as those using turkey herpesvirus (HVT-VP2), are gaining attention due to their safety and ability to induce long-lasting immunity without causing bursal damage¹. 

Biosecurity and Farm Management 

Vaccination alone cannot control IBD. The virus is highly resistant and can persist in poultry houses for up to 122 days¹. Strict hygiene, disinfection, and control of mechanical vectors like rodents and insects are essential components of disease management. 

Subclinical infections, often overlooked, are a major cause of economic loss due to poor growth and increased susceptibility to other diseases. 

Conclusion 

Effective control of IBD requires a multi-pronged approach combining accurate diagnostics, strategic vaccination, and stringent biosecurity. For veterinarians, the focus should shift from routine protocols to evidence-based, flock-specific strategies. As the virus continues to evolve, so must our approach to managing it in the field. 

Reference 

1. Dey S, Pathak DC, Ramamurthy N, Maity HK, Chellappa MM. Infectious bursal disease virus in chickens: prevalence, impact, and management strategies. Veterinary Medicine: Research and Reports. 2019 Aug 5:85-97. https://www.tandfonline.com/doi/pdf/10.2147/VMRR.S185159 
2. Maity HK, Dey S, Mohan CM, Khulape SA, Pathak DC, Vakharia VN. Protective efficacy of a DNA vaccine construct encoding the VP2 gene of infectious bursal disease and a truncated HSP70 of Mycobacterium tuberculosis in chickens. Vaccine. 2015 Feb 18;33(8):1033-9. https://www.academia.edu/download/41685094/Protective_efficacy_of_a_DNA_vaccine_con20160128-6556-6cun3j.pdf